New drug trial aims to boost energy in cancer patients
Symptom relief
Not yet recruiting
This study is testing an investigational drug called AND017 to see if it is safe and effective for treating anemia (low red blood cells) in people with cancer who are receiving chemotherapy. The main goal is to see if AND017 can increase hemoglobin levels, which could help reduce…
Phase: PHASE2 • Sponsor: Kind Pharmaceuticals LLC • Aim: Symptom relief
Last updated Apr 09, 2026 19:32 UTC